[ET Net News Agency, 23 May 2018] CSPC Pharmaceutical (01093) said the Group's
"Qimaite" (tramadol hydrochloride tablets (50mg)) has been granted approval by the China
Food and Drug Administration for passing the consistency of quality and efficacy
evaluation of generic drugs.
The Group is the first one passing the consistency evaluation for this type of drug in
China.
Tramadol hydrochloride tablet is a pain medication of the non-morphine variety. It is
mainly used for the treatment of adult pains which are severe as to require the use of
opioid analgesics and have inadequate alternative therapy. (HL)